<DOC>
	<DOCNO>NCT02164812</DOCNO>
	<brief_summary>The purpose study determine whether multiple dos Efavirenz effect QTc interval ( correct Fridericia ) CYP2B6 *1/*6 *6/*6 healthy subject .</brief_summary>
	<brief_title>Study Determine Effect Efavirenz ECG QTcF Interval Healthy Subjects</brief_title>
	<detailed_description>CYP = Cytochrome p-450 Primary Purpose : Other : This Phase 1 clinical pharmacology thorough QT study conduct post marketing requirement</detailed_description>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy volunteer , age 18 49 year old BMI 18 32 kg/m2 Women must pregnant breastfeed A personal history clinically relevant cardiac disease , symptomatic asymptomatic arrhythmia , presyncope syncopal episode , additional risk factor torsades de pointes ( eg , heart failure ) History hypokalemia , personal history family history prolong QT interval , family history sudden cardiac death young age Any follow 12lead electrocardiogram ( ECG ) prior study drug administration : PR ≥210 msec , QRS ≥120 msec , QT ≥500 msec , QTcF ≥450 msec , HR &lt; 45 bpm Second third degree heart block prior study drug Positive urine screen drug abuse Positive blood screen hepatitis C antibody , hepatitis B surface antigen , Human Immunodeficiency Virus ( HIV ) 1 , 2 antibody Any follow lab result outside range specify prior dosing : Alanine aminotransferase ( ALT ) &gt; upper limit normal ( ULN ) , aspartate aminotransferase ( AST ) &gt; ULN , Total bilirubin &gt; ULN , Direct bilirubin &gt; ULN , Creatinine &gt; ULN , Serum potassium &lt; low limit normal ( LLN ) , Serum magnesium &lt; LLN History allergy Moxifloxacin , Efavirenz relate compound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>